Create Alert
Watchlist

Granules India

₹564.75
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
554.90
Prev. Close
564.75
Volume
0
Total traded value
NA
Upper Circuit
677.70
Lower Circuit
451.80

Fundamentals

Market Cap₹13,455Cr
ROE12.88%
P/E Ratio(TTM)26.24
EPS(TTM)21.13
P/B Ratio3.38
Dividend Yield0.27%
Industry P/E32.95
Book Value164.12
Debt to Equity0.45
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Granules India

With a four-decade legacy, Granules India evolved from an API maker into a vertically integrated, global pharmaceutical company with a world-class manufacturing platform. Its vision is to become a world leader in the green chemical and pharmaceutical industry by using cutting-edge technologies to enhance the quality of life. The company is propelled by its purpose of 'Healing Lives Responsibly through Pioneering Green Science,' delivering safe, effective, and affordable medicines across geographies. It operates across the value chain, delivering high-quality Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs) to worldwide healthcare markets. Granules is strategically expanding into high-growth areas like oncology and peptides to build a differentiated portfolio that underpins sustained global competitiveness. This global strategy supports its supply of 100+ molecules to over 300 customers in 80+ countries, backed by a manufacturing capacity of 10 billion dosages.;
Parent OrganisationGranules India Limited
Managing DirectorDr. K.V.S. Ram Rao
Founded1991
NSE SymbolGRANULES

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
38.82%
Retail And Others
29.17%
Foreign Institutions
14.09%
Other Domestic Institutions
11.38%
Mutual Funds
6.54%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.50
Emcure Pharmaceuticals
NA
(0.00%)
32.62
Wockhardt
NA
(0.00%)
-424.60
Cohance Lifesciences
NA
(0.00%)
64.50
2025
13
Nov
Quarterly Result
Release date
12
Aug
Quarterly Result
Release date

31
Jul
Dividend
Ex date
₹1.50
per share

For each share you hold, you will receive ₹1.50
Dividend amount₹1.50 per share
Dividend TypeFinal
Ex Date31 Jul ‘25
Record Date31 Jul ‘25
Announcement date28 May ‘25

28
May
Dividend
Announced
₹1.50
per share

For each share you hold, you will receive ₹1.50
Dividend amount₹1.50 per share
Dividend TypeFinal
Ex Date31 Jul ‘25
Record Date31 Jul ‘25
Announcement date28 May ‘25
28
May
Annual Result
Release date
24
Jan
Quarterly Result
Release date
2024
6
Nov
Quarterly Result
Release date

30
Jul
Dividend
Ex date
₹1.50
per share

For each share you hold, you will receive ₹1.50
Dividend amount₹1.50 per share
Dividend TypeFinal
Ex Date30 Jul ‘24
Record Date30 Jul ‘24
Announcement date15 May ‘24
30
Jul
Quarterly Result
Release date

15
May
Dividend
Announced
₹1.50
per share

For each share you hold, you will receive ₹1.50
Dividend amount₹1.50 per share
Dividend TypeFinal
Ex Date30 Jul ‘24
Record Date30 Jul ‘24
Announcement date15 May ‘24
15
May
Quarterly & Annual Result
Release date
Events calendar
View upcoming events in other stocks